English | 繁體

Search in the results

UM

Browse/Search Results:  1-5 of 5 Help

Selected(0)Clear Items/Page:    Sort:
Ginsenoside Rh2 augmented anti-PD-L1 immunotherapy by reinvigorating CD8+ T cells via increasing intratumoral CXCL10 Journal article
Huang, Mu Yang, Chen, Yu Chi, Lyu, Wen Yu, He, Xin Yu, Ye, Zi Han, Huang, Can Yu, He, Xin Ling, Chen, Xiuping, Chen, Xiaobing, Zhang, Baoxian, Kai, Guoyin, Zhang, Xiaolei, Li, Ting, Huang, Mingqing, Lu, Jin Jian. Ginsenoside Rh2 augmented anti-PD-L1 immunotherapy by reinvigorating CD8+ T cells via increasing intratumoral CXCL10[J]. Pharmacological Research, 2023, 198, 106988.
Authors:  Huang, Mu Yang;  Chen, Yu Chi;  Lyu, Wen Yu;  He, Xin Yu;  Ye, Zi Han; et al.
Favorite | TC[WOS]:10 TC[Scopus]:14  IF:9.1/9.0 | Submit date：2024/01/02
Combination Treatment  Ginsenoside Rh2  Pd-1/pd-l1  t Cells  Tumor Microenvironment  
Combined inhibition of pyruvate dehydrogenase kinase 1 and lactate dehydrogenase a induces metabolic and signaling reprogramming and enhances lung adenocarcinoma cell killing Journal article
Zhou, Yan, Guo, Yizhen, Ran, Maoxin, Shan, Wenying, Granchi, Carlotta, Giovannetti, Elisa, Minutolo, Filippo, Peters, Godefridus J., Tam, Kin Yip. Combined inhibition of pyruvate dehydrogenase kinase 1 and lactate dehydrogenase a induces metabolic and signaling reprogramming and enhances lung adenocarcinoma cell killing[J]. Cancer Letters, 2023, 577, 216425.
Authors:  Zhou, Yan;  Guo, Yizhen;  Ran, Maoxin;  Shan, Wenying;  Granchi, Carlotta; et al.
Favorite | TC[WOS]:9 TC[Scopus]:7  IF:9.1/8.3 | Submit date：2023/12/04
Anticancer  Combination Treatment  Non-small Cell Lung Cancer  Warburg Effect  
CDK inhibitors from past to present: A new wave of cancer therapy Journal article
Muhammad Jameel Mughal, Kinjal Bhadresha, Hang Fai Kwok. CDK inhibitors from past to present: A new wave of cancer therapy[J]. Seminars in Cancer Biology, 2023, 88, 106-122.
Authors:  Muhammad Jameel Mughal;  Kinjal Bhadresha;  Hang Fai Kwok
Favorite | TC[WOS]:37 TC[Scopus]:36  IF:12.1/13.2 | Submit date：2023/02/08
Cancer Therapeutic Regimen  Cell Cycle  Combination Treatment  Cyclin-dependent Kinase Inhibitor  
Essential Role of Chinese Medicines in Mesenchymal Stem Cells Transplantation for Treatment of Ischemic Stroke Journal article
Zhao,Yong hua. Essential Role of Chinese Medicines in Mesenchymal Stem Cells Transplantation for Treatment of Ischemic Stroke[J]. Chinese Journal of Integrative Medicine, 2019, 25(10), 723-727.
Authors:  Zhao,Yong hua
Favorite | TC[WOS]:2 TC[Scopus]:5  IF:2.2/2.3 | Submit date：2021/03/02
Chinese Medicines  Combination Treatment  Ischemic Stroke  Mesenchymal Stem Cell  
Combined effects of furanodiene and doxorubicin on the migration and invasion of MDA-MB-231 breast cancer cells in vitro Journal article
Zhong, Zhang-Feng, Tan, Wen, Tian, Ke, Yu, Hua, Qiang, Wen-An, Wang, Yi-Tao. Combined effects of furanodiene and doxorubicin on the migration and invasion of MDA-MB-231 breast cancer cells in vitro[J]. ONCOLOGY REPORTS, 2017, 37(4), 2016-2024.
Authors:  Zhong, Zhang-Feng;  Tan, Wen;  Tian, Ke;  Yu, Hua;  Qiang, Wen-An; et al.
Favorite | TC[WOS]:27 TC[Scopus]:30  IF:3.8/3.4 | Submit date：2018/10/30
Furanodiene  Doxorubicin  Combination Treatment  Breast Cancer  Migration  Invasion